20 May 2016
MSD Animal Health and Europharma team up to change future supply chain for trout vaccines
SCOTLAND, UK, May 20, 2016 – MSD Animal Health, the market leader in aquaculture welfare, (known as Merck Animal Health in the United States and Canada) has teamed up with Europharma UK in an exclusive deal to provide the best possible service in the distribution of its trout health products. Europharma, experts in providing tailored distribution to minimise threats to fish health and welfare, will work closely with MSD Animal Health to ensure a smooth transition in the distribution of its trout health products including AQUAVAC® ERM, AQUAVAC®ERM Oral and AQUAVAC® RELERA.
Nikos Steiropoulos of Europharma UK said:
“We are excited about working in partnership with MSD Animal Health in the distribution of their trout health products, to ensure the best service to customers. This new partnership will give our customers the benefit of our experience and specialist knowledge, developed over many years supporting the aquaculture industry, and will help producers achieve sustainable and profitable production.”
Europharma brings a wealth of experience to the market, including their FISHGUARD programme, a 360 degree ‘Veterinary Husbandry’ approach which combines veterinary medicine and animal husbandry.
Dedicated Europharma personnel will be on hand to offer bespoke advice and experience, where requested, in key fields such as nutrition, water quality, recirculation, breeding and fish biology, to ensure the smoothest transition for the new distribution method.
Dafydd Morris, Business Manager of Aquaculture at MSD Animal Health, added:
“Operating as our exclusive wholesaler, Europharma brings a wealth of experience to the market including on site aquaculture veterinary support who can advise and support the growth of the service where required.”
In advance of the new service going live, customer workshops were held across the UK, offering the trout industry, from vets to producers, the opportunity to meet with representatives of MSD Animal Health and Europharma to discuss how to make best use of the opportunities this change will bring.